Unexpected drug residuals in human milk in Ankara, capital of Turkey

Table 5 Impact of “breast milk NSAID residues” and “maternal NSAID usage during early postpartum period” on the on the maternal BMI change after birth and infant WAZ and HCZ values on admission, multivariate analysis

Breast milk residue	Maternal NSAID usage during postpartum period			Overall	P for residue	P for maternal self-use	Interaction between residue and self-use
Breast milk residue		Absence	Presence	Overall	P for residue	P for maternal self-use	Interaction between residue and self-use
Maternal BMI change after birth^a
NSAID	–	−2.77 ± 0.55	−1.38 ± 0.46	− 2.07 ± 0.35	0.017	0.038	0.938
NSAID	+	−1.26 ± 0.73	0.23 ± 0.81	− 0.51 ± 0.53
Overall		−2.01 ± 0.46	−0.57 ± 0.47
Infant’s WAZ^b
NSAID	–	−0.13 ± 0.20	−0.10 ± 0.16	− 0.11 ± 0.13	0.555	0.895	0.805
NSAID	+	0.07 ± 0.23	−0.02 ± 0.32	0.03 ± 0.19
Overall		−0.03 ± 0.15	−0.06 ± 0.18

Values were mean ± standart error of mean
^a Analysed with general linear models adjusted for maternal age, smoke exposure, gestational length, birth type, maternal BMI at birth, maternal disease, breastfeeding type, infant age
^b Exclusive breast fed infants were enrolled and analysed with general linear models adjusted for maternal age, maternal disease, smoke exposure, gestational length, birth type, infant’s WAZ at birth, infant age

ISSN: 1471-2393